Effects of ursolic acid on different steps of the angiogenic process

Biochemical and Biophysical Research Communications

Volumn 320, Issue 2, 2004, Pages 402-408

  Cárdenas, Casimiro ^a   Quesada, Ana R ^a   Medina, Miguel Ángel ^a  

^a UNIVERSITY OF MÁLAGA   (Spain)

Author keywords

Angiogenesis; BAEC; Endothelial cells; Triterpenoid; Ursolic acid

Indexed keywords

GELATINASE A; UROKINASE; URSOLIC ACID;

ANGIOGENESIS; ANIMAL CELL; ANTIANGIOGENIC ACTIVITY; ARTICLE; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME DEGRADATION; EXTRACELLULAR MATRIX; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CATTLE; CELLS, CULTURED; COLLAGEN; DRUG COMBINATIONS; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX; HYDROLYSIS; LAMININ; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEOGLYCANS; TRITERPENES;

EID: 2942741025     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.05.183     Document Type: Article

References (38)

1. Mahato S.B., Sarkar S.K., Poddar G. Triterpenoid saponins. Phytochemistry. 27:1988;3037-3067
2. Liu J. Pharmacology of oleanoic acid and ursolic acid. J. Ethnopharmacol. 49:1995;57-68
3. Kim D.K., Baek J.H., Kang C.M., Yoo M.A., Sung J.W., Chung H.Y., Kim N.D., Choi Y.H., Lee S.H., Kim K.W. Apoptotic activity of ursolic acid may correlate with the inhibition of initiation of DNA replication. Int. J. Cancer. 87:2000;629-636
4. Hollosy F., Meszaros G., Bokonyi G., Idei M., Seprodi A., Szende B., Keri G. Cytostatic, cytotoxic and protein tyrosine kinase inhibitory activity of ursolic acid in A431 human tumor cells. Anticancer Res. 20:2000;4563-4570
5. Najid A., Simon A., Cook J., Chable-Rabinovitch H., Delage C., Chulia A.J., Rigaud M. Characterization of ursolic acid as a lipoxygenase and cyclooxygenase inhibitor using macrophages, platelets and differentiated HL60 leukemic cells. FEBS Lett. 299:1992;213-217
6. Suh N., Honda T., Finlay H.J., Barchowsky A., Williams C., Benoit N.E., Xie Q.W., Nathan C., Gribble G.W., Sporn M.B Novel triterpenoids suppress inducible nitric oxide synthase (iNOS) and inducible cyclooxygenase (COX-2) in mouse macrophages. Cancer Res. 58:1998;717-723
7. Subbaramaiah K., Michaluart P., Sporn M.B., Dannenberg A.J. Ursolic acid inhibits cyclooxygenase-2 transcription in human mammary epithelial cells. Cancer Res. 60:2000;2399-2404
8. Shishodia S., Majumdar S., Banerjee S., Aggarwal B.B. Ursolic acid inhibits nuclear factor-κB activation induced by carcinogenic agents through suppression of IκBα kinase and p65 phosphorylation: correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1. Cancer Res. 63:2003;4375-4383
9. Harmand P.O., Duval R., Liagre B., Jayat-Vignoles C., Beneytout J.L., Delage C., Simon A. Ursolic acid induces apoptosis through caspase-3 activation and cell cycle arrest in HaCat cells. Int. J. Oncol. 23:2003;105-112
10. 2+ release mediates ursolic acid-induced apoptosis in human leukemic HL-60 cells. Int. J. Cancer. 73:1997;725-728
11. Huang M.T., Ho C.T., Wang Z.Y., Ferraro T., Lou Y.R., Stauber K., Ma W., Georgiadis C., Laskin J.D., Conney A.H. Inhibition of skin tumorigenesis by rosemary and its constituents carnosol and ursolic acid. Cancer Res. 54:1994;701-708
12. Manez S., Recio M.C., Giner R.M., Ríos J.L. Effect of selected triterpenoids on chronic dermal inflammation. Eur. J. Pharmacol. 334:1997;103-105
13. Sohn K.H., Lee H.Y., Chung H.Y., Young H.S., Yi S.Y., Kim K.W. Anti-angiogenic activity of triterpene acids. Cancer Lett. 94:1995;213-218
14. Carmeliet P. Angiogenesis in health and disease. Nat. Med. 9:2003;653-660
15. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell. 100:2000;57-70
16. Harris A.L. Anti-angiogenesis therapy and strategies for integrating it with adjuvant therapy. Recent Results Cancer Res. 152:1998;341-352
17. Rodríguez-Nieto S., González-Iriarte M., Carmona R., Muñoz-Chápuli R., Medina M.A., Quesada A.R. Antiangiogenic activity of aeroplysinin-1, a brominated compound isolated from a marine sponge. FASEB J. 2001;. 10.1096/fj.01-0427fje
18. Castro M.E., González-Iriarte M., Barrero A.F., Salvador-Tormo N., Muñoz-Chápuli R., Medina M.A., Quesada A.R. Study of puupehenone and related compounds as inhibitors of angiogenesis. Int. J. Cancer. 110:2004;31-38
19. García de Veas R., Schweigerer L., Medina M.A. Modulation of the proteolytic balance plasminogen activator/plasminogen activator inhibitor by enhanced N-myc oncogene expression or application of genistein. Eur. J. Cancer. 34:1998;1736-1740
20. Fajardo I., Quesada A.R., Núñez de Castro I., Sanchez-Jimenez F., Medina M.A. A comparative study of the effects of genistein and 2-methoxyestradiol on the proteolytic balance and tumour cell proliferation. Br. J. Cancer. 80:1999;17-24
21. Rodríguez-Nieto S., Chavarría T., Martínez-Poveda B., Sánchez-Jiménez F., Quesada A.R., Medina M.A. Anti-angiogenic effects of homocysteine on cultured endothelial cells. Biochem. Biophys. Res. Commun. 293:2002;497-500
22. Igura K., Ohta T., Kuroda Y., Kaji K. Resveratrol and quercetin inhibit angiogenesis in vitro. Cancer Lett. 171:2001;11-16
23. Shimamura M., Hazato T., Ashino H., Yamamoto Y., Iwasaki E., Tobe H., Yamamoto K., Yamamoto S. Inhibition of angiogenesis by humulone, a bitter acid from beer hop. Biochem. Biophys. Res. Commun. 289:2001;220-224
24. Gourly M., Williamson J.S. Angiogenesis: new targets for the development of anticancer chemotherapies. Curr. Pharm. Des. 6:2000;417-439
25. Dormond O., Foletti A., Paroz C., Ruegg C. NSAIDs inhibit alpha V beta 3 integrin-mediated and Cdc42/Rac-dependent endothelial-cell spreading, migration and angiogenesis. Nat. Med. 7:2001;1041-1047
26. Griggs J., Metcalfe J.C., Hesketh R. Targeting tumor vasculature: the development of combretastatin A4. Lancet Oncol. 2:2001;82-87
27. Vincent L., Che W., Hong L., Mirshahi F., Misal Z., Mirshahi-Khorassani T., Vannier J.P., Soria J., Soria C. Inhibition of endothelial cell migration by cerivastatin, an HMG-CoA reductase inhibitor: contribution to its anti-angiogenic effect. FEBS Lett. 495:2001;159-166
28. Kang J.A., Kim J.T., Song H.S., Bae M.K., Yi E.Y., Kim K.W., Kim Y.J. Anti-angiogenic and anti-tumor invasive activities of tissue inhibitor of metalloproteinase-3 from shark, Scyliorhinus torazame. Biochim. Biophys. Acta. 1620:2003;59-64
29. Cha H.J., Bae S.K., Lee H.Y., Lee O.H., Sato H., Seiki M., Park B.C., Kim K.W. Anti-invasive activity of ursolic acid correlates with the reduced expression of matrix metalloproteinase-9 (MMP-9) in HT1080 human fibrosarcoma cells. Cancer Res. 56:1996;2281-2284
30. Liotta L.A., Steeg P.S., Stetler-Stevenson W.G. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell. 64:1991;327-336
31. Stetler-Stevenson W.G. Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention. J. Clin. Invest. 103:1999;1237-1241
32. Egeblad M., Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer. 2:2002;163-176
33. Pepper M.S., Belin D., Montesano R., Orci L., Vasalli J.D. Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro. J. Cell Biol. 111:1990;743-755
34. Rakic J.M., Maillard C., Jost M., Bajou K., Masson V., Devy L., Lambert V., Foidart J.M., Noël A. Role of plasminogen activator-plasmin system in tumor angiogenesis. Cell. Mol. Life Sci. 60:2003;463-473
35. Cha H.J., Park M.T., Chung H.Y., Kim N.D., Sato H., Seiki M., Kim K.W. Ursolic acid-induced down-regulation of MMP-9 gene is mediated through the nuclear translocation of glucocorticoid receptor in HY1080 human fibrosarcoma cells. Oncogene. 16:1998;771-778
36. Hisa T., Kimura Y., Takada K., Suzuki F., Takigawa M. Shikonin, an ingredient of Lithospermum erythrorhizon, inhibits angiogenesis in vivo and in vitro. Anticancer Res. 18:1998;782-790
37. Thaloor D., Singh A.K., Sidhu G.S., Prasad P.V., Kleinman H.K., Maheswari R.K. Inhibition of angiogenic differentiation of human umbilical endothelial cells by curcumin. Cell Growth Differ. 9:1998;305-312
38. Kim M.S., Lee Y.M., Moon E.J., Kim S.E., Lee J.J., Kim K.W. Antiangiogenic activity of torilin, a sesquiterpene compound isolated from Torilis japonica. Int. J. Cancer. 87:2000;269-275